Back
Danaher 10K Form
Sell
40
DHR
Danaher
Last Price:
250.19
Seasonality Move:
10.75%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-04-23 | 10Q | DHR/Danaher Quarterly |
| 2024-02-21 | 10K | DHR/Danaher Annual |
| 2023-10-24 | 10Q | DHR/Danaher Quarterly |
| 2023-07-25 | 10Q | DHR/Danaher Quarterly |
| 2023-04-25 | 10Q | DHR/Danaher Quarterly |
| 2023-02-22 | 10K | DHR/Danaher Annual |
Receive DHR News And Ratings
See the #1 stock for the next 7 days that we like better than DHR
DHR Financial Statistics
Sales & Book Value
| Annual Sales: | $23.89B |
|---|---|
| Cash Flow: | $1.22B |
| Price / Cash Flow: | 37.26 |
| Annual Sales: | $71.03 |
| Price / Book: | 3.52 |
Profitability
| EPS (TTM): | 5.24000 |
|---|---|
| Net Income (TTM): | $3.89B |
| Gross Margin: | $14.03B |
| Return on Equity: | 7.47% |
| Return on Assets: | 4.69% |
Danaher Earnings Forecast
Key Danaher Financial Ratios
- The Gross Profit Margin over the past 40 years for DHR is 58.74%.
- The Selling, General & Administrative Expenses for DHR have been equal to 30.36% of Gross Profit Margin.
- The Research & Development expenses have been 6.29% of Revenue.
- The Interest Expense is 6.00% of Operating Income.
- The Net Earning history of DHR is 19.94% of Total Revenues.
- Per Share Earnings over the last 40 years have been positive in 27 years.
Danaher Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Life Sciences Tools & Services |
| Sector: | Health Care |
| Current Symbol: | DHR |
| CUSIP: | 235851 |
| Website: | danaher.com |
Debt
| Debt-to-Equity Ratio: | 0.34 |
|---|---|
| Current Ratio: | 1.37 |
| Quick Ratio: | 0.84 |
Price-to-Earnings
| Trailing P/E Ratio: | 39.2 |
|---|---|
| Forward P/E Ratio: | 29.64 |